Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

ClinicalTrials.gov ID: NCT00003736

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00003736. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 16, 2026, 12:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pilot Study: High Risk Breast Cancer Screening Pilot Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for breast cancer. Diagnostic procedures such as MRI may improve the ability to detect breast cancer. PURPOSE: Screening and diagnostic trial to study the effectiveness of MRI scans in women who are at high risk for developing breast cancer.

Study identification

NCT ID
NCT00003736
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
25 Years to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1999 (Type not available)
Primary completion
Jun 2002 (Actual)
Completion
Jun 2002 (Actual)
Last update posted
Sep 24, 2019

1999 – 2002

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128 —
University of Colorado Cancer Center Denver Colorado 80010 —
Porter Adventist Hospital Denver Colorado 80210 —
Hartford Hospital Hartford Connecticut 06102-5037 —
Lombardi Cancer Center Washington D.C. District of Columbia 20007 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295 —
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104-4283 —
Simmons Cancer Center - Dallas Dallas Texas 75235-9154 —
Cancer Center at the University of Virginia Charlottesville Virginia 22908 —
University of Washington Medical Center Seattle Washington 98195-6043 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2019 · Synced Nov 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.